Alhopuro et al. [44] studied patients with leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck, and their results indicated essentially the same proportion of individuals with MDM2 polymorphism as noted in our investigation. This evidence concerns the gene MDM2 and squamous cell carcinoma.